Correlation Between Tandem Diabetes and NISOURCE

Can any of the company-specific risk be diversified away by investing in both Tandem Diabetes and NISOURCE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tandem Diabetes and NISOURCE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tandem Diabetes Care and NISOURCE FIN P, you can compare the effects of market volatilities on Tandem Diabetes and NISOURCE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tandem Diabetes with a short position of NISOURCE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tandem Diabetes and NISOURCE.

Diversification Opportunities for Tandem Diabetes and NISOURCE

0.09

Correlation Coefficient

Tandem Diabetes  NISOURCE

Significant diversification

The 3 months correlation between Tandem and NISOURCE is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and NISOURCE FIN P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NISOURCE FIN P and Tandem Diabetes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tandem Diabetes Care are associated (or correlated) with NISOURCE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NISOURCE FIN P has no effect on the direction of Tandem Diabetes i.e., Tandem Diabetes and NISOURCE go up and down completely randomly.

Pair Corralation between Tandem Diabetes and NISOURCE

Given the investment horizon of 90 days Tandem Diabetes Care is expected to generate 3.63 times more return on investment than NISOURCE. However, Tandem Diabetes is 3.63 times more volatile than NISOURCE FIN P. It trades about 0.06 of its potential returns per unit of risk. NISOURCE FIN P is currently generating about 0.0 per unit of risk. If you would invest  2,399  in Tandem Diabetes Care on October 7, 2024 and sell it today you would earn a total of  1,284  from holding Tandem Diabetes Care or generate 53.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	64.32%
Values	Daily Returns

Tandem Diabetes Care  vs.  NISOURCE FIN P

Tandem Diabetes Care

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tandem Diabetes Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

NISOURCE FIN P

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NISOURCE FIN P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for NISOURCE FIN P investors.

Pair Trading with Tandem Diabetes and NISOURCE

The main advantage of trading using opposite Tandem Diabetes and NISOURCE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tandem Diabetes position performs unexpectedly, NISOURCE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NISOURCE will offset losses from the drop in NISOURCE's long position.

The idea behind Tandem Diabetes Care and NISOURCE FIN P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.